Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebellar Modulation of Cognition in Psychosis

NCT06107764 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT06107764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06107764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebellar Modulation of Cognition in Psychosis
Lead sponsor
Mclean Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 31, 2024
Completion date
December 31, 2029
Enrollment
95 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder i, psychosis, schizoaffective disorder, schizophrenia